Tags

Type your tag names separated by a space and hit enter

Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion. Systematic review and meta-analysis of randomised trials.
J Neurol Neurosurg Psychiatry. 2017 Apr; 88(4):339-345.JN

Abstract

INTRODUCTION

It is unclear whether intensive lowering of blood pressure (BP) at the acute phase of intracerebral haemorrhage (ICH) is beneficial. We performed a meta-analysis of randomised controlled trials (RCTs) to assess whether intensive BP lowering in patients with acute ICH is safe and effective in improving clinical outcomes.

METHODS

We searched PubMed, EMBASE and the Cochrane databases for relevant RCTs and calculated pooled OR for 3-month mortality (safety outcome) and 3-month death or dependency (modified Rankin Scale (mRs) ≥3;efficacy outcome), in patients with acute ICH randomised to either intensive BP-lowering or standard BP-lowering treatment protocols. We also investigated the association between treatment arm and ICH expansion at 24 hours. Random effects models with DerSimonian-Laird weights were used.

RESULTS

Five eligible studies including 4360 patients with acute ICH were pooled in meta-analysis. The risk of 3-month mortality was similar between patients randomised to intensive BP-lowering treatment and standard BP-lowering treatment (OR: 0.99; 95% CI: 0.82 to 1.20, p=0.909). Intensive BP-lowering treatment showed a (non-significant) trend for an association with lower 3-month death or dependency risk compared with standard treatment (OR: 0.91; 95% CI: 0.80 to 1.02), p=0.106). Intensive BP reduction was associated with a trend for lower risk of significant ICH expansion compared with standard treatment (OR: 0.82; 95% CI: 0.68 to 1.00, p=0.056), especially in larger RCTs.

CONCLUSIONS

For patients with acute ICH similar to those included in RCTs and without contraindication to acute BP treatment, intensive acute BP lowering is safe, but does not seem to provide an incremental clinical benefit in terms of functional outcomes. The effect of intensive BP lowering on significant haematoma expansion at 24 hours warrants further investigation.

Authors+Show Affiliations

Hemorrhagic Stroke Research Group, Massachusetts General Hospital, Boston, Massachusetts, USA. Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA. Department of Neuroradiology, Centre Hospitalier Sainte-Anne, Université Paris-Descartes, INSERM UMR 894, Paris, France.Hemorrhagic Stroke Research Group, Massachusetts General Hospital, Boston, Massachusetts, USA. Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.Hemorrhagic Stroke Research Group, Massachusetts General Hospital, Boston, Massachusetts, USA. Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA. Division of Neurocritical Care and Emergency Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.Hemorrhagic Stroke Research Group, Massachusetts General Hospital, Boston, Massachusetts, USA andreas.charidimou.09@ucl.ac.uk. Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.

Pub Type(s)

Journal Article
Meta-Analysis
Review
Systematic Review

Language

eng

PubMed ID

28214798

Citation

Boulouis, Gregoire, et al. "Intensive Blood Pressure Lowering in Patients With Acute Intracerebral Haemorrhage: Clinical Outcomes and Haemorrhage Expansion. Systematic Review and Meta-analysis of Randomised Trials." Journal of Neurology, Neurosurgery, and Psychiatry, vol. 88, no. 4, 2017, pp. 339-345.
Boulouis G, Morotti A, Goldstein JN, et al. Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion. Systematic review and meta-analysis of randomised trials. J Neurol Neurosurg Psychiatry. 2017;88(4):339-345.
Boulouis, G., Morotti, A., Goldstein, J. N., & Charidimou, A. (2017). Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion. Systematic review and meta-analysis of randomised trials. Journal of Neurology, Neurosurgery, and Psychiatry, 88(4), 339-345. https://doi.org/10.1136/jnnp-2016-315346
Boulouis G, et al. Intensive Blood Pressure Lowering in Patients With Acute Intracerebral Haemorrhage: Clinical Outcomes and Haemorrhage Expansion. Systematic Review and Meta-analysis of Randomised Trials. J Neurol Neurosurg Psychiatry. 2017;88(4):339-345. PubMed PMID: 28214798.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion. Systematic review and meta-analysis of randomised trials. AU - Boulouis,Gregoire, AU - Morotti,Andrea, AU - Goldstein,Joshua N, AU - Charidimou,Andreas, Y1 - 2017/02/18/ PY - 2016/11/24/received PY - 2017/01/25/revised PY - 2017/02/01/accepted PY - 2017/2/20/pubmed PY - 2017/5/18/medline PY - 2017/2/20/entrez KW - Acute Therapy KW - Blood Pressure KW - Hematoma Expansion KW - Hypertension KW - Intracerebral Hemorrhage KW - Meta-Analysis KW - Outcome KW - Stroke SP - 339 EP - 345 JF - Journal of neurology, neurosurgery, and psychiatry JO - J Neurol Neurosurg Psychiatry VL - 88 IS - 4 N2 - INTRODUCTION: It is unclear whether intensive lowering of blood pressure (BP) at the acute phase of intracerebral haemorrhage (ICH) is beneficial. We performed a meta-analysis of randomised controlled trials (RCTs) to assess whether intensive BP lowering in patients with acute ICH is safe and effective in improving clinical outcomes. METHODS: We searched PubMed, EMBASE and the Cochrane databases for relevant RCTs and calculated pooled OR for 3-month mortality (safety outcome) and 3-month death or dependency (modified Rankin Scale (mRs) ≥3;efficacy outcome), in patients with acute ICH randomised to either intensive BP-lowering or standard BP-lowering treatment protocols. We also investigated the association between treatment arm and ICH expansion at 24 hours. Random effects models with DerSimonian-Laird weights were used. RESULTS: Five eligible studies including 4360 patients with acute ICH were pooled in meta-analysis. The risk of 3-month mortality was similar between patients randomised to intensive BP-lowering treatment and standard BP-lowering treatment (OR: 0.99; 95% CI: 0.82 to 1.20, p=0.909). Intensive BP-lowering treatment showed a (non-significant) trend for an association with lower 3-month death or dependency risk compared with standard treatment (OR: 0.91; 95% CI: 0.80 to 1.02), p=0.106). Intensive BP reduction was associated with a trend for lower risk of significant ICH expansion compared with standard treatment (OR: 0.82; 95% CI: 0.68 to 1.00, p=0.056), especially in larger RCTs. CONCLUSIONS: For patients with acute ICH similar to those included in RCTs and without contraindication to acute BP treatment, intensive acute BP lowering is safe, but does not seem to provide an incremental clinical benefit in terms of functional outcomes. The effect of intensive BP lowering on significant haematoma expansion at 24 hours warrants further investigation. SN - 1468-330X UR - https://www.unboundmedicine.com/medline/citation/28214798/Intensive_blood_pressure_lowering_in_patients_with_acute_intracerebral_haemorrhage:_clinical_outcomes_and_haemorrhage_expansion__Systematic_review_and_meta_analysis_of_randomised_trials_ L2 - https://jnnp.bmj.com/lookup/pmidlookup?view=long&pmid=28214798 DB - PRIME DP - Unbound Medicine ER -